特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
933262

医薬品製造受託機関(CMO)の世界市場:新型コロナウイルス感染症(COVID-19)の影響と回復の過程

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020-30: Covid 19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 300 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
医薬品製造受託機関(CMO)の世界市場:新型コロナウイルス感染症(COVID-19)の影響と回復の過程
出版日: 2020年04月22日
発行: The Business Research Company
ページ情報: 英文 300 Pages
納期: 2-3営業日
担当者のコメント
COVID-19の感染の懸念がいまだ世界的に続く中、各製薬会社のCMO開拓戦略も大きく変わってくると予想されております。COVIDの影響を考慮した最新のCMO市場動向をまとめた調査レポートが英国の調査会社、TBRCよりリリースされました。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の医薬品製造受託機関(CMO)市場を調査し、市場の概要、タイプ・主要地域・国別の市場規模の推移と予測(過去5年間・今後10年間分)、市場シェア、成長率、市場の成長要因および阻害要因の分析、近年の主な合併・買収(M&A)動向、市場戦略、成長が見込まれる投資分野、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

当レポートがお答えする疑問

  • 医薬品製造受託機関(CMO)の最大かつ急成長している市場はどこか?
  • 医薬品製造受託機関(CMO)市場は、経済全体、人口動態、および他の類似市場とどのように関係しているか?
  • 今後、どのような力学が市場を形成していくのか?
  • 医薬品製造受託機関(CMO)市場の過去の成長動向、新型コロナウイルス感染症の影響とその回復の予測

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場規模と成長率

  • 市場規模(実績値)
    • 市場の成長要因
    • 市場の阻害要因
  • 市場規模(予測値)
    • 市場の成長要因
    • 市場の阻害要因

第4章 医薬品製造受託機関(CMO)の世界市場:セグメント別

  • 市場規模:タイプ別(実績値・予測値)

第5章 医薬品製造受託機関(CMO)市場の分析:地域・国別

  • 市場規模:地域別(実績値・予測値)
  • 市場規模:国別(実績値・予測値)

第6章 アジア太平洋地域の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第7章 中国の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第8章 インドの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第9章 日本の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第10章 オーストラリアの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第11章 インドネシアの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第12章 韓国の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第13章 西欧の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第14章 英国の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第15章 ドイツの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第16章 フランスの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第17章 東欧の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第18章 ロシアの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第19章 北米の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第20章 米国の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第21章 南米の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第22章 ブラジルの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第23章 中東の医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第24章 アフリカの医薬品製造受託機関(CMO)市場

  • 市場概要
  • 市場規模:タイプ別(実績値・予測値)

第25章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Recipharm AB
    • Pfizer Inc.
    • Catalent Pharma Solutions
    • Aenova Group
    • Famar

第26章 主な合併・買収(M&A)動向

第27章 市場動向と戦略

第28章 市場展望と潜在性の分析

第29章 付録

目次

‘Pharmaceutical Contract Development And Manufacturing Market Global Report 2020: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical contract development and manufacturing market as it emerges from the Covid 19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the pharmaceutical contract development and manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? ‘The Pharmaceutical Contract Development And Manufacturing market global report ’ from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical contract development and manufacturing market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The pharmaceutical contract development and manufacturing market section of the report gives context. It compares the pharmaceutical contract development and manufacturing market with other segments of the pharmaceutical contract development and manufacturing market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmaceutical contract development and manufacturing indicators comparison.

Scope:

  • Markets Covered: 1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing; Finished Dosage Formulation (FDF) Development & Manufacturing; Secondary Packaging
  • Companies Mentioned: Recipharm AB; Pfizer Inc.; Catalent Pharma Solutions; Aenova Group; Famar
  • Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Pharmaceutical Contract Development And Manufacturing Market Characteristics

3. Pharmaceutical Contract Development And Manufacturing Market Size And Growth

  • 3.1. Global Pharmaceutical Contract Development And Manufacturing Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Pharmaceutical Contract Development And Manufacturing Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Pharmaceutical Contract Development And Manufacturing Market Segmentation

  • 4.1. Global Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5. Pharmaceutical Contract Development And Manufacturing Market Regional And Country Analysis

  • 5.1. Global Pharmaceutical Contract Development And Manufacturing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Pharmaceutical Contract Development And Manufacturing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market

  • 6.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Overview
  • 6.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Pharmaceutical Contract Development And Manufacturing Market

  • 7.1. China Pharmaceutical Contract Development And Manufacturing Market Overview
  • 7.2. China Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Pharmaceutical Contract Development And Manufacturing Market

  • 8.1. India Pharmaceutical Contract Development And Manufacturing Market Overview
  • 8.2. India Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Pharmaceutical Contract Development And Manufacturing Market

  • 9.1. Japan Pharmaceutical Contract Development And Manufacturing Market Overview
  • 9.2. Japan Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Pharmaceutical Contract Development And Manufacturing Market

  • 10.1. Australia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Pharmaceutical Contract Development And Manufacturing Market

  • 11.1. Indonesia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Pharmaceutical Contract Development And Manufacturing Market

  • 12.1. South Korea Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Pharmaceutical Contract Development And Manufacturing Market

  • 13.1. Western Europe Pharmaceutical Contract Development And Manufacturing Market Overview
  • 13.2. Western Europe Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Pharmaceutical Contract Development And Manufacturing Market

  • 14.1. UK Pharmaceutical Contract Development And Manufacturing Market Overview
  • 14.2. UK Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Pharmaceutical Contract Development And Manufacturing Market

  • 15.1. Germany Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Pharmaceutical Contract Development And Manufacturing Market

  • 16.3. France Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market

  • 17.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market Overview
  • 17.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Pharmaceutical Contract Development And Manufacturing Market

  • 18.1. Russia Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Pharmaceutical Contract Development And Manufacturing Market

  • 19.1. North America Pharmaceutical Contract Development And Manufacturing Market Overview
  • 19.2. North America Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Pharmaceutical Contract Development And Manufacturing Market

  • 20.1. USA Pharmaceutical Contract Development And Manufacturing Market Overview
  • 20.2. USA Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Pharmaceutical Contract Development And Manufacturing Market

  • 21.1. South America Pharmaceutical Contract Development And Manufacturing Market Overview
  • 21.2. South America Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Pharmaceutical Contract Development And Manufacturing Market

  • 22.1. Brazil Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Pharmaceutical Contract Development And Manufacturing Market

  • 23.1. Middle East Pharmaceutical Contract Development And Manufacturing Market Overview
  • 23.2. Middle East Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Pharmaceutical Contract Development And Manufacturing Market

  • 24.1. Africa Pharmaceutical Contract Development And Manufacturing Market Overview
  • 24.2. Africa Pharmaceutical Contract Development And Manufacturing Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Pharmaceutical Contract Development And Manufacturing Market Competitive Landscape And Company Profiles

  • 25.1. Pharmaceutical Contract Development And Manufacturing Market Competitive Landscape
  • 25.2. Pharmaceutical Contract Development And Manufacturing Market Company Profiles
    • 25.2.1. Recipharm AB
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Pfizer Inc.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Catalent Pharma Solutions
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Aenova Group
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Famar
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Market

27. Pharmaceutical Contract Development And Manufacturing Market Trends And Strategies

28. Pharmaceutical Contract Development And Manufacturing Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.